Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX - Cavender, Matthew A.; Harrington, Robert A.; Stone, Gregg W.; Steg, Ph. Gabriel; Gibson, C. Michael; Hamm, Christian W.; Price, Matthew J.; Lopes, Renato D.; Leonardi, Sergio; Deliargyris, Efthymios N.; Prats, Jayne; Mahaffey, Kenneth W.; et al. (Circulation. Cardiovascular interventions, 2022)
Keywords: Adenosine Monophosphate - adverse effects; Adenosine Monophosphate - analogs & derivatives; Clopidogrel - adverse effects; Humans; Myocardial Infarction - etiology; Original; Percutaneous Coronary Intervention - adverse effects; Platelet Aggregation Inhibitors - adverse effects; Purinergic P2Y Receptor Antagonists - adverse effects; Thrombosis - etiology; Treatment Outcome; coronary artery disease; percutaneous coronary intervention; thrombosis; myocardial infarction; P2Y12 receptor antagonist